Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Karyotype is an independent pr...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
Bibliographic Details
Main Authors:
Moorman, A
,
Harrison, C
,
Buck, G
,
Richards, S
,
Secker-Walker, L
,
Martineau, M
,
Vance, G
,
Cherry, A
,
Higgins, R
,
Fielding, A
,
Foroni, L
,
Paietta, E
,
Tallman, MS
,
Litzow, MR
,
Wiernik, P
,
Rowe, J
,
Goldstone, A
,
Dewald, G
Format:
Conference item
Published:
2007
Holdings
Description
Similar Items
Staff View
Similar Items
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
by: Moorman, A, et al.
Published: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
by: Moorman, A, et al.
Published: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
by: Moorman, A, et al.
Published: (2005)
Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
by: Rowe, J, et al.
Published: (2008)
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
by: Fielding, A, et al.
Published: (2009)